<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors identified persistent Th activation in five of seven children (71.4%) diagnosed as having Fanconi's <z:hpo ids='HP_0001903'>anemia</z:hpo> or <z:e sem="disease" ids="C1260899" disease_type="Disease or Syndrome" abbrv="BDS">Diamond-Blackfan syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Th reactivity was no longer present in one patient after bone marrow transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>Tests on family members and other patients with bone marrow dysfunctions of childhood showed no Th activation </plain></SENT>
<SENT sid="3" pm="."><plain>Less than 1 percent of healthy children or blood donors had Th activation </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with a variety of hemolytic and hypoplastic conditions also had a low incidence of Th activation </plain></SENT>
<SENT sid="5" pm="."><plain>However, 13.5 percent of cord blood specimens demonstrated Th reactivity </plain></SENT>
<SENT sid="6" pm="."><plain>This study indicates that Th activation may be a red cell developmental marker present in <z:hpo ids='HP_0004810'>congenital hypoplastic anemias</z:hpo> and also expressed on newborn red cells </plain></SENT>
</text></document>